Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
1,204 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Tardive dyskinesia and cognitive performances in late-life depression: a sex-stratified analysis.
Luca A, Luca M, Drago F, Serretti A. · Psychiatry Res · 2026 · cited 0 timesclinical trial, phase i, randomized controlled trial
- Efficacy and safety of different pharmacological interventions in the treatment of tardive dyskinesia: a systematic review and network meta-analysis.
Ismail O, Albdour K, Jaber Y, Jaber K, Alsaras A. · Eur J Clin Pharmacol · 2026 · cited 0 timessystematic review, network meta-analysis
- Factors Predicting the Efficacy of Valbenazine and Exacerbation of Tardive Dyskinesia After Valbenazine Discontinuation in Japanese Patients: A Post Hoc Analysis of the J-KINECT Study.
Watanabe Y, Susuta Y, Masui H, Takeuchi H. · J Clin Psychopharmacol · 2026 · cited 0 timesOpen accessmulticenter study, randomized controlled trial
- Improvements Over Time with Valbenazine in Elderly Adults (≥65 Years) with Tardive Dyskinesia: Post Hoc Analyses of 2 Long-Term Studies.
Sajatovic M, Alexopoulos GS, Jen E, Farahmand K, Zinger C. · J Clin Psychiatry · 2025 · cited 4 timesclinical trial, phase iii, research support, non-u.s. gov't
- Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis.
Solmi M, Fornaro M, Caiolo S, Lussignoli M, Caiazza C, De Prisco M, Solini N, de Bartolomeis A, Iasevoli F, Pigato G, Del Giovane C, Cipriani A, Correll CU. · Mol Psychiatry · 2025 · cited 17 timessystematic review, network meta-analysis
- Tardive Dyskinesia with Antipsychotic Medication in Children and Adolescents: A Systematic Literature Review.
Besag FMC, Vasey MJ, Salim I, Hollis C. · Drug Saf · 2024 · cited 7 timessystematic review
- Efficacy and safety of different pharmacological interventions in the treatment of tardive dyskinesia: a systematic review and network meta-analysis.
Ismail O, Albdour K, Jaber Y, Jaber K, Alsaras A. · Eur J Clin Pharmacol · 2024 · cited 4 timesretracted publication, systematic review
- Transcranial direct current stimulation improves tardive dyskinesia in long-term hospitalized patients with chronic schizophrenia.
Lyu X, Li Z, Chen S, Gu S, Zhou Z, Yang R, Yang P, Zhang G, Li C, Yuan N, Yin M, Zhang W, Wei X, Huang X, Du X. · Clin Neurophysiol · 2024 · cited 4 timesrandomized controlled trial
- Tardive dyskinesia in Asia- current clinical practice and the role of neurologists in the care pathway.
Bhidayasiri R, Phokaewvarangkul O, Shang HF, Lim TT, Cho JW, Pal PK, Watanabe H. · Front Neurol · 2024 · cited 5 timesOpen accesssystematic review, systematic-review
- A Model-Informed Drug Development Approach Supporting the Approval of an Unstudied Valbenazine Dose for Patients With Tardive Dyskinesia.
Nguyen HQ, Kuan HS, Crass RL, Quinlan L, Chapel S, Kim K, Brar S, Loewen G. · J Clin Pharmacol · 2024 · cited 3 timesresearch support, non-u.s. gov't, randomized controlled trial
- Efficacy and Safety of Valbenazine in Elderly and Nonelderly Japanese Patients With Tardive Dyskinesia: A Post Hoc Analysis of the J-KINECT Study.
Watanabe Y, Susuta Y, Nagano M, Masui H, Kanahara N. · J Clin Psychopharmacol · 2024 · cited 3 timesmulticenter study, randomized controlled trial
- Sustained Treatment Response and Global Improvements With Long-term Valbenazine in Patients With Tardive Dyskinesia.
Correll CU, Citrome L, Singer C, Lindenmayer JP, Zinger C, Liang G, Dunayevich E, Marder SR. · J Clin Psychopharmacol · 2024 · cited 1 timesclinical trial, phase iii, multicenter study
- Comparative Analysis of Deutetrabenazine and Valbenazine as VMAT2 Inhibitors for Tardive Dyskinesia: A Systematic Review.
Golsorkhi M, Koch J, Pedouim F, Frei K, Bondariyan N, Dashtipour K. · Tremor Other Hyperkinet Mov (N Y) · 2024 · cited 15 timesOpen accesscomparative study, systematic review
- Ginkgo biloba for Tardive Dyskinesia and Plasma MnSOD Activity: Association with MnSOD Ala-9Val Variant: A Randomized, Double-blind Trial.
Wang D, Tian Y, Chen J, Zhu R, Li J, Zhou H, Chen D, Wang L, Kosten TR, Zhang XY. · Curr Neuropharmacol · 2024 · cited 1 timesOpen accessrandomized controlled trial
- Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder: Primary Results and Post Hoc Analyses of the J-KINECT Study.
Nagano M, Susuta Y, Masui H, Watanabe Y, Watanabe K. · J Clin Psychopharmacol · 2024 · cited 2 timesclinical trial, phase ii, multicenter study
- Vitamin E in the treatment of tardive dyskinesia: a meta-analysis.
Xu H, Qin H, Chen S, Guan M. · Int Clin Psychopharmacol · 2022 · cited 6 timesmeta-analysis
- A systematic review on the use of clozapine in treatment of tardive dyskinesia and tardive dystonia in patients with psychiatric disorders.
Wong J, Pang T, Cheuk NKW, Liao Y, Bastiampillai T, Chan SKW. · Psychopharmacology (Berl) · 2022 · cited 17 timessystematic review
- Efficacy and safety of valbenazine in Japanese patients with tardive dyskinesia: A multicenter, randomized, double-blind, placebo-controlled study (J-KINECT).
Horiguchi J, Watanabe K, Kondo K, Iwatake A, Sakamoto H, Susuta Y, Masui H, Watanabe Y. · Psychiatry Clin Neurosci · 2022 · cited 14 timesOpen accessclinical trial, phase ii, multicenter study
- Antipsychotic-induced movement disorders among patients with severe mental illness in Africa: A systematic review and meta-analysis.
Yiglet Z, Kibralew G, Tadesse H, Molla W, Workie Y, Demelash D, Fasil B, Sahle A, Demelash D, Endeshaw W, Getnet M, Kelebie M. · Compr Psychiatry · 2026 · cited 0 timesmeta-analysis, systematic review
- Efficacy and safety of Transcranial Direct Current Stimulation (tDCS) on cognitive function in chronic schizophrenia with Tardive Dyskinesia (TD): a randomized, double-blind, sham-controlled, clinical trial.
Zhou Y, Xia X, Zhao X, Yang R, Wu Y, Liu J, Lyu X, Li Z, Zhang G, Du X. · BMC Psychiatry · 2023 · cited 14 timesOpen accessresearch support, non-u.s. gov't, randomized controlled trial
- Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazine.
Hauser RA, Barkay H, Wilhelm A, Wieman M, Savola JM, Gordon MF. · Parkinsonism Relat Disord · 2022 · cited 6 timesrandomized controlled trial
- Pharmacologic Treatment of Tardive Dyskinesia: A Meta-Analysis and Systematic Review.
Artukoglu BB, Li F, Szejko N, Bloch MH. · J Clin Psychiatry · 2020 · cited 13 timesmeta-analysis, systematic review
- Benzodiazepines for antipsychotic-induced tardive dyskinesia.
Bergman H, Bhoopathi PS, Soares-Weiser K. · Cochrane Database Syst Rev · 2018 · cited 15 timesmeta-analysis, research support, non-u.s. gov't
- The effects of valbenazine on tardive dyskinesia in older and younger patients.
Sajatovic M, Alexopoulos GS, Burke J, Farahmand K, Siegert S. · Int J Geriatr Psychiatry · 2020 · cited 11 timesOpen accessresearch support, non-u.s. gov't, randomized controlled trial
- Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review.
Pardis P, Remington G, Panda R, Lemez M, Agid O. · J Psychopharmacol · 2019 · cited 39 timessystematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.